BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3081431)

  • 1. Sequences 3' of immunoglobulin heavy chain genes influence their expression.
    Gregor PD; Kobrin BJ; Milcarek C; Morrison SL
    Immunol Rev; 1986 Feb; 89():31-48. PubMed ID: 3081431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelomas and lymphomas expressing the Ig gamma 2a H chain gene have similar transcription termination regions.
    Flaspohler JA; Milcarek C
    J Immunol; 1990 Apr; 144(7):2802-10. PubMed ID: 2108214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
    Elmaleh N; Matthias P; Schaffner W
    Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements.
    Grosschedl R; Baltimore D
    Cell; 1985 Jul; 41(3):885-97. PubMed ID: 3924411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. During B-cell differentiation enhancer activity and transcription rate of immunoglobulin heavy chain genes are high before mRNA accumulation.
    Gerster T; Picard D; Schaffner W
    Cell; 1986 Apr; 45(1):45-52. PubMed ID: 3082521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of a B-cell-specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression.
    Zaller DM; Eckhardt LA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5088-92. PubMed ID: 3927296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells.
    Schibler U; Marcu KB; Perry RP
    Cell; 1978 Dec; 15(4):1495-509. PubMed ID: 103631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells.
    Kobrin BJ; Milcarek C; Morrison SL
    Mol Cell Biol; 1986 May; 6(5):1687-97. PubMed ID: 2878362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 3' alpha-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation.
    Michaelson JS; Giannini SL; Birshtein BK
    Nucleic Acids Res; 1995 Mar; 23(6):975-81. PubMed ID: 7731812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes containing the IgH enhancer in non-lymphoid cells.
    Klein BY; Morrison SL
    Mol Immunol; 1990 Aug; 27(8):713-22. PubMed ID: 2119478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence.
    Mason JO; Williams GT; Neuberger MS
    Cell; 1985 Jun; 41(2):479-87. PubMed ID: 3921262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved patterns of somatic mutation and secondary VH gene rearrangement create aberrant Ig-encoding genes in Epstein-Barr virus-transformed and normal human B lymphocytes.
    Brokaw JL; Wetzel SM; Pollok BA
    Int Immunol; 1992 Feb; 4(2):197-206. PubMed ID: 1377945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma mutant with a novel 3' flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy-chain gene products.
    Gregor PD; Morrison SL
    Mol Cell Biol; 1986 Jun; 6(6):1903-16. PubMed ID: 3023910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-specific expression of secreted versus membrane forms of immunoglobulin gamma 2b mRNA involves selective use of alternate polyadenylation sites.
    Milcarek C; Hall B
    Mol Cell Biol; 1985 Oct; 5(10):2514-20. PubMed ID: 3939252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mRNA stabilities affect mRNA levels in mutant mouse myeloma cells.
    Genovese C; Harrold S; Milcarek C
    Somat Cell Mol Genet; 1991 Jan; 17(1):69-81. PubMed ID: 1900133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters that govern the regulation of immunoglobulin delta heavy-chain gene expression.
    Tisch R; Kondo N; Hozumi N
    Mol Cell Biol; 1990 Oct; 10(10):5340-8. PubMed ID: 2118995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-lymphocyte targeting of gene expression in transgenic mice with the immunoglobulin heavy-chain enhancer.
    Gerlinger P; LeMeur M; Irrmann C; Renard P; Wasylyk C; Wasylyk B
    Nucleic Acids Res; 1986 Aug; 14(16):6565-77. PubMed ID: 3092186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
    Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; MÃ¥rtensson IL
    Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.
    Gillies SD; Morrison SL; Oi VT; Tonegawa S
    Cell; 1983 Jul; 33(3):717-28. PubMed ID: 6409417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.